Hydromorphon Long Aristo

Hydromorphone, the active ingredient in Hydromorphon Long Aristo, is an opioid analgesic presented as an oral tablet for oral use. It provides analgesia for severe acute, cancer‑related and postoperative pain in adult patients.

GNH USA supplies Hydromorphon Long Aristo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.

Hydromorphon Long Aristo is an opioid analgesic used to manage pain conditions that require strong opioid therapy. - Severe acute pain: delivers rapid and potent analgesia for intense pain episodes. - Cancer‑related pain: helps control persistent pain associated with malignant disease. - Post‑operative pain: reduces pain following surgical procedures, facilitating recovery.

Hydromorphon Long Aristo may cause a range of adverse reactions, some of which are dose‑dependent.

Common Side Effects: - Nausea: feeling of sickness or urge to vomit. - Constipation: reduced bowel movements and hard stools. - Drowsiness: increased sleepiness or fatigue. - Dizziness: sensation of light‑headedness or unsteadiness. - Dry mouth: reduced salivation leading to a parched feeling. - Pruritus: mild itching of the skin.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing that can be life‑threatening. - Hypotension: significant drop in blood pressure causing faintness. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Dependence or addiction: potential for misuse with prolonged use. - Withdrawal syndrome: symptoms upon abrupt discontinuation after prolonged therapy. - QT prolongation: rare cardiac rhythm disturbance.

When prescribing Hydromorphon Long Aristo, clinicians should consider several safety measures. - Assess pain severity: confirm that opioid therapy is appropriate for the level of pain. - Evaluate respiratory function: avoid use in patients with compromised breathing. - Monitor for constipation: implement prophylactic laxatives as needed. - Caution in renal/hepatic impairment: dose adjustments may be required. - Avoid concurrent CNS depressants: limit use with alcohol or benzodiazepines. - Store at ambient temperature: keep below 25 °C in the original container, protected from moisture and light.

Hydromorphon Long Aristo can interact with other medications, altering its efficacy or safety profile.

Major Interactions (Avoid): - Other opioids: additive respiratory depression and sedation. - Benzodiazepines: increased risk of profound CNS depression. - MAO inhibitors: potential for severe hypotension and serotonin syndrome.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., ketoconazole): may raise hydromorphone plasma levels. - CYP3A4 inducers (e.g., rifampin): may reduce analgesic effect. - Anticholinergics: can worsen constipation. - Diuretics: may enhance hypotensive effects.